Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical

Summary: Recent scientific advances in anti-aging science are bringing the dream of the fountain of youth closer to reality. More than just extending our lifespans, the field hopes to significantly reduce the chronic diseases of aging, such as cancer, heart disease, and dementia. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ]

A fountain of youth has been the dream of humanity throughout history.

Recent scientific advances are bringing that dream closer to reality.

Read more

Summary: Why the bowhead whale lives 200 years and rarely gets cancer. This article is part 2 of a 3-part series, covering the role of telomere length in cancer and part of a new extensive study. Part 1 on the accuracy of telomere length is here, Part 3 on the role of telomere length in chronic diseases is here. [This article first appeared under the title ‘Top Journal Discovers Key to These 200-Year-Old Whales Who Avoid Cancer’ on the website LongevityFacts.com. Author: Brady Hartman. ]

Related: A brief overview of why whales don’t get cancer is in this companion video.

In a comprehensive study published a little more than a week ago in a highly respected journal of the Royal Society of the UK, authors Abraham Aviv and Jerry W. Shay (see author bios here) report on the role of telomere length. In this segment, the authors describe the role of telomere length in protecting us from cancer and explain why whales have low rates of cancer, despite large cell counts, long lives, and relatively short telomeres.

Read more

Summary: A recently announced parabiosis trial in humans – the practice of transfusing young blood to old – may have profound implications for treating the chronic diseases of old age, including metabolic changes, frailty, Alzheimer’s, Parkinson’s, and other forms of dementia. However, some geroscientists say that variations of the procedure could cause severe side effects. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ]

The idea that youthful blood might rejuvenate our aging bodies has lingered in the popular imagination for centuries, fueled by recent experiments in which these transfusions revitalized aging mice.

Last week, Bill Faloon of the Life Extension Foundation (LEF) in partnership with the Young Blood Institute (YBI), announced a bold new human trial of the rejuvenating effects of the young blood / old blood swap, saying.

Read more

Five technologies in development – including senolytic drugs, rapamycin, stem cell therapy, NAD supplementation and gene therapy – could dramatically slow down aging in the next few years. This report updates the latest developments in these promising and potentially lifespan-extending treatments. [This article first appeared on the website LongevityFacts. Author: Brady Hartman. ]

The longevity science field has made enormous progress in recent years, and human trials of anti-aging compounds have already started, with more to begin soon. The lifespan-extension research field is gaining the attention of mainstream medicine.

The specialists who populate the field, called geroscientists, are developing several technologies that might benefit people who are alive today and aim to bring them to the clinic. These lifespan-extending technologies include stem cell therapy, rapamycin, gene therapy, senolytic drugs, and NAD supplementation.

Read more

Summary: Designer babies have recently become possible, as new techniques have gained credibility from serious scientists. Here’s how they can do it. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

On Feb 8, the AHA named “Fixing a gene mutation in human embryos” as among the “top advances in heart disease and stroke research” of the past year. They joined a chorus of voices heralding this as a research breakthrough.

The announcement brought attention to the fact that US scientists have recently demonstrated the plausibility of using gene editing to make designer babies.

Read more

Human gene therapy trials are reporting promising results, according to Liz Parrish, the CEO of BioViva and patient zero in a test of gene therapy on her own body.

Liz Parrish says she’s ‘mind-blown’ by the success of gene therapy trials. She is the BioViva CEO who tested gene therapy on her own body.

Read more

Summary: In a medical first, scientists at CWRU have inhibited metastasis – the spread of cancer cells to another part of the body. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

In a first of its kind victory, researchers from the Case Western Reserve University (CWRU) School of Medicine and six other institutions have inhibited the spread of cancer cells from one part of the body to another.

To accomplish this feat, the team relied on a novel epigenetic model of how cancer metastasizes. Epigenetics is the master program which turns genes on and off. The group included researchers from the National Cancer Institute (NCI) and the Cleveland Clinic. The researchers published their results in the journal Nature Medicine.

Read more

Right in moment when Olympic games 2018 had started, founders of DAYS longevity accelerator and one of renowned longevity organizations leader have decided on running a sort of Olimpic games in life science, aiming to identify the world champions in area that really matters for everyone (life extension).

W hat is problem, why so important issue have no visible signs of progress?

If you’re sort of between 40 and older male, 40% of you will never reach the age of 74. Why multiple brilliant inventions of diagnostic and cure technologies have no financing and adoption in clinics?

Read more

https://www.stitcher.com/podcast/reaching-the-finish-line/e/53287380?autoplay=true